Benzinga

OCTOBER 4, 2024

Following the transactions, OnKure is expected to have a cash runway through multiple clinical readouts and into Q4-2026. "We 04, 2024 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. and Reneo Pharmaceuticals, Inc. The combined company will operate under the name OnKure Therapeutics, Inc., President and Chief Executive Officer of OnKure.

Alpha 45

Alpha Marketability 45

Benzinga

NOVEMBER 3, 2023

and its shares are expected to begin trading on the Nasdaq Capital Market under the ticker symbol "KRRO" on November 6, 2023. and LEXINGTON, Mass., 03, 2023 (GLOBE NEWSWIRE) -- Korro Bio, Inc. ((Frequency, NASDAQ: FREQ ) and the entity formerly known as Korro Bio, Inc. Korro Bio).

Alpha 45

Alpha Marketability 45

Musings on Markets

OCTOBER 28, 2024

In keeping with my inability to stay focused, that then led me to also think about sovereign wealth funds, an increasingly powerful presence in both private and public equity markets, and then about green energy, a favored destination for impact investors over the last two decades.

Start-ups 66

Start-ups Alpha Equity Marketability 66